| Detected | Trial | Change |
|---|---|---|
| 2026-08-06 | NCT06006403 Safety and Efficacy of CD123-targeted CAR-NK for Relapsed/Refractory Acute Myeloid… |
Trial completed |
| 2026-08-06 | NCT06006403 Safety and Efficacy of CD123-targeted CAR-NK for Relapsed/Refractory Acute Myeloid… |
Enrollment reduced: 36 -> 5 participants |
| 2026-08-06 | NCT06006403 Safety and Efficacy of CD123-targeted CAR-NK for Relapsed/Refractory Acute Myeloid… |
date change Primary completion moved earlier: 2025-12-31 -> 2025-09-25 |
| 2026-08-06 | NCT06006403 Safety and Efficacy of CD123-targeted CAR-NK for Relapsed/Refractory Acute Myeloid… |
date change Completion moved earlier: 2026-08-31 -> 2025-12-31 |
| 2026-08-02 | NCT05334823 A Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in… |
overall status: Recruiting → Unknown |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-07-20 | NCT07715630 In Vivo PICX CAR-T Therapy for R/R Multiple Myeloma | Phase 1 | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 1/2 | |||
| NCT06006390 | CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA… | Gastric Cancer | Recruiting |
| NCT04271644 | BCMA-Targeted CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma and Plasma Cell… | Multiple Myeloma | Recruiting |
| NCT04776330 | a Clinical Research of BCMA-Targeted Prime CAR-T Cell Therapy in Relapsed/Refractory… | Multiple Myeloma | Recruiting |
| NCT04781634 | a Clinical Research of CD19 and CD22 Targeted Prime CAR-T Cell in Relapsed/Refractory… | B-ALL | Recruiting |
| Phase 1 | |||
| NCT06043466 | A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive… | Colorectal Cancer | Recruiting |
| NCT06056921 | Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune Disease | SLE (Systemic Lupus) | Recruiting |
| NCT06010862 | Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic… | Gastric Cancer | Recruiting |
| NCT06010875 | A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive… | Renal Cell Carcinoma | Recruiting |
| NCT06126406 | Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes（CAR-T） for CEA… | Gastric Cancer | Recruiting |
| NCT06180174 | Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/Refractory B Cell Lymphoma | B Cell Lymphoma | Recruiting |
| NCT06215950 | A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive… | Ovarian Cancer | Recruiting |
| NCT06569472 | Clinical Trial of CD19-targeted CAR-T Therapy for Refractory Juvenile Dermatomyositis | Juvenile Dermatomyositis | Recruiting |
| NCT06686524 | Clinical Study of CD19 Targeted Universal Chimeric Antigen Receptor T Lymphocytes… | Dermatomyositis, Juvenile | Recruiting |
| NCT06690827 | Clinical Trial of CD123-targeted CAR-NK Therapy for Relapse/refractory AML or BPDCN | AML (Acute Myeloid Leukemia) | Recruiting |
| NCT06768151 | A Clinical Trial of CEA Targeting CAR-T for CEA Positive Advanced Lung Cancer | Advanced Lung Cancer | Recruiting |
| NCT06903117 | Anti-CEA CAR-T for Advanced CEA-Positive Lung Carcinoma | Advanced Lung Cancer | Recruiting |
| NCT06909474 | Clinical Trial of CD5-targeted CAR-NK Therapy for Relapse/Refractory T-Cell Hematologic… | T-ALL/Lymphoma | Recruiting |
| NCT06992583 | Targeted Anti-CEA CAR-T Immunotherapy for Advanced Lung Cancer | Advanced Lung Cancer | Recruiting |
| NCT06945523 | Clinical Study on Chimeric Antigen Receptor T Lymphocyte (CAR-T) Targeting CEA for the… | Advanced Lung Cancer | Recruiting |
| NCT07184450 | Clinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic… | Juvenile Dermatomyositis (JDM) | Recruiting |
| NCT07179692 | CEA-Targeted CAR-T Therapy in CEA-Positive Advanced Solid Tumors | Lung Cancer | Recruiting |
| NCT07181720 | CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors | Renal Cell Carcinoma (RCC) | Recruiting |
| NCT07239323 | In VIVO CAR-T Therapy for Relapsed/Refractory Hematological Malignancies | B-Acute Lymphoblastic Leukemia | Recruiting |
| NCT06892145 | Clinical Trial of CD19 Targeted CAR-T Cell in Refractory Adult SLE | Systemic Lupus Erythematosus (SLE) | Recruiting |
| NCT07331467 | Study of Ultra-Fast CD19 CAR-T Therapy for Refractory SLE | Systemic Lupus Erythematosus | Recruiting |